Table 4.
Subgroup analysis of different intervention strategies in n = 1016 patients.
| Treatment | IVT | IVT + EVT | EVT | |||
|---|---|---|---|---|---|---|
| Group | AM | C | AM | C | AM | C |
| Patients (n) | 38 | 534 | 22 | 259 | 19 | 144 |
| Systemic bleeding | 0 (0.0) | 4 (0.7) | 1 (4.5) | 6 (2.3) | 1 (5.3) | 4 (2.8) |
| STR systemic bleeding | 0 (0.0) | 1 (0.2) | 0 (0.0) | 4 (1.5) | 0 (0.0) | 1 (0.7) |
| SICH | 2 (5.3) | 15 (2.8) | 3 (13.6) | 18 (6.9) | 1 (5.3) | 11 (7.6) |
| STR SICH | 2 (5.3) | 15 (2.8) | 2 (9.0) | 16 (6.2) | 0 (0.0) | 9 (6.3) |
| ICH | 7 (18.4) | 52 (9.7) | 8 (36.4) | 45 (17.4) | 4 (21.0) | 23 (16.0) |
| STR ICH | 7 (18.4) | 50 (9.3) | 7 (31.8) | 41 (15.8) | 1 (5.3) | 17 (11.8) |
Data are presented in n and n (%) in relation to each subgroup, respectively.
AM, active malignancy group; C, control group; EVT, endovascular therapy; ICH, intracranial hemorrhage; IVT, intravenous thrombolysis; SICH, symptomatic intracranial hemorrhage; STR, stroke treatment related.